VANGUARD GROUP INC 13D and 13G filings for Gilead Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:06 pm Sale |
2023-12-29 | 13G | Gilead Sciences, Inc. GILD |
VANGUARD GROUP INC | 111,820,711 8.970% |
-217,613 (-0.19%) |
Filing |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Gilead Sciences, Inc. GILD |
VANGUARD GROUP INC | 112,038,324 8.930% |
6,234,525 (+5.89%) |
Filing |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Gilead Sciences, Inc. GILD |
VANGUARD GROUP INC | 105,803,799 8.430% |
3,016,782 (+2.93%) |
Filing |
| 2021-02-10 10:57 am Sale |
2020-12-31 | 13G | Gilead Sciences, Inc. GILD |
VANGUARD GROUP INC | 102,787,017 8.200% |
-984,831 (-0.95%) |
Filing |